License to Cure for Medical Device
Accelerate the delivery of innovative, safe and fully compliant medical devices
Connect systems, people and data in a virtual ecosystem to drive innovation and generate competitive advantage
Driving transformation to achieve breakthrough innovation and improve patient experiences
Business success is driven to a great extent by the creation of new revenue streams (i.e. innovation) and operational excellence. During the last decade, Life Sciences companies have been divided into numerous isolated divisions. To manage this, many created complex matrix-based organizations attempting to enhance cross-division communication and data exchange to streamline internal processes, but much more is required.
Organizations that digitalize their businesses by embracing the principles and technology that deliver digital continuity across the entire innovation continuum will win. This will better serve the drive toward open innovation, research and engineering, manufacturing and the ultimate delivery of differentiated patient experiences. It will transform the way they innovate and operate, driving significantly enhanced margins with patient centric experiences and increased productivity and profits.
Maximize ecosystem engagement to:
|Foster innovation across your enterprise connecting people with the best ideas.||Excel in business operations to drive profitability and product quality.|
|Increase competitive advantage with disruptive, holistic patient centric experiences.|
Connecting people with data enables quicker, more informed decisions, while infusing virtualization and simulation throughout the development and manufacturing continuum. This helps ensure therapies are produced ‘As designed’ and ‘As registered’ in the most cost-effective and high-quality manner.
The 3DEXPERIENCE® platform enables Life Sciences companies to create experiences to satisfy unmet medical needs and improve patient outcomes in global markets in one virtual environment (exploration, discovery, development, testing, commercialization) – with full visibility across their internal and external ecosystems.
Discover Dassault Systèmes®' Life Sciences industry solutions aiming to improve patient and physician experience, and organizational business excellence.
Bristol-Myers Squibb ELN is a critical first step rather than a magic bullet. Implementing an ELN enables organizations to begin to centralize electronic data and identify legacy tasks and processes that are unnecessary in an electronic workflow.
"The transition from paper-based systems to electronic ones is the most productive transition we will make as an industry."